[1]
“THE UTILIZATION OF DIOSGENIN FOR MANAGING THE GENETICALLY TRANSMITTED OPTIC NERVE SHEATH MENINGIOMAS (ONSMS)”,
JRA
, vol. 6, no. 1, Feb. 2024, Accessed: Apr. 13, 2025. [Online]. Available:
https://journlra.org/index.php/jra/article/view/1427